Product Details

Veruro-CV Dry Syrup combines a second-generation cephalosporin with a beta-lactamase inhibitor for the effective treatment of resistant bacterial infections. Specifically, each 5ml of reconstituted syrup delivers Cefuroxime Axetil equivalent to 200mg Cefuroxime together with Potassium Clavulanate equivalent to 125mg Clavulanic Acid. As a result, it offers broad-spectrum antibacterial coverage extended by resistance protection in a convenient liquid formulation.

The syrup combines:

• Cefuroxime Axetil IP (equivalent to Cefuroxime 200mg per 5ml) – A second-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins. Consequently, it exerts bactericidal activity against a broad range of gram-positive and gram-negative organisms.
• Potassium Clavulanate IP (equivalent to Clavulanic Acid 125mg per 5ml) – A beta-lactamase inhibitor that protects Cefuroxime from degradation by bacterial enzymes. As a result, it extends Cefuroxime’s effectiveness against resistant strains that would otherwise inactivate it.

Physicians prescribe Veruro-CV for the treatment of bacterial infections resistant to standard cephalosporin therapy, including respiratory tract infections, urinary tract infections, and skin and soft tissue infections. In addition, its dry syrup format, reconstituted before use, supports accurate dosing and easier administration than tablets. Because of this profile, Veruro-CV suits general practice and hospital settings treating resistant bacterial infections.

Key Features:

• Overall, this combination formulation guarantees pharmaceutical-grade purity across both actives
• Additionally, the beta-lactamase inhibitor extends antibacterial coverage against resistant strains
• Furthermore, each 5ml delivers precise, validated dosage accuracy at 200mg + 125mg
• Notably, rigorous quality testing backs every stage of manufacturing
• Beyond that, light-protected bottle packaging preserves syrup stability
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, clinics, and pharmacies